Bridge Bank Provides $15MM Facility to CytoSorbents
CytoSorbents, a critical care immunotherapy leader specializing in blood purification, refinanced its existing $10 million term loan with a new $15 million debt facility with Bridge Bank.
April 5, 2018
Bridge Bank | CytoSorbents | Justin McDonie
ABF Journal